Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 3, 2011, Pages

  Moreira, Ronaldo I ^a   Luz, Paula M ^a   Struchiner, Claudio J ^b   Morgado, Mariza ^c   Veloso, Valdilea G ^a   Keruly, Jeanne C ^d   Grinsztejn, Beatriz ^a   Moore, Richard D ^d  

^a Funda??o Oswaldo Cruz   (Brazil)

^b Programa de Computacxão Cient ifica   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

care; HIV AIDS; immunodefi ciency; late diagnosis presentation

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HEALTH CARE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; VIRUS LOAD;

ADULT; BALTIMORE; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 79960750658     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821e9d59     Document Type: Article

References (20)

1. Althoff KN, Gange SJ, Klein MB, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50:1512-1520.
2. Brannstrom J, Akerlund B, Arneborn M, et al. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002-a remaining problem in the highly active antiretroviral therapy era. Int J STD AIDS. 2005;16:702-706. (Pubitemid 41527355)
3. Wolbers M, Bucher HC, Furrer H, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med. 2008;9:397-405. (Pubitemid 352015643)
4. Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12:61-64.
5. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(suppl 1):S3-S8. (Pubitemid 47312320)
6. Phillips A, Pezzotti P. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS. 2004;18:51-58. (Pubitemid 38402317)
7. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453. (Pubitemid 41003791)
8. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-2098.
9. Souza-Jr PR, Szwarcwald CL, Castilho EA. Delay in introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003-2006. Clinics (Sao Paulo). 2007;62:579-584.
10. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(suppl 1):S38-S41. (Pubitemid 128708058)
11. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 ,200 cells/microL) with HIV infection. HIV Med. 2004;5:93-98. (Pubitemid 38404662)
12. Lanoy E, May M, Mocroft A, et al. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS. 2009;23: 2199-2208.
13. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-1450. (Pubitemid 43948252)
14. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis. 2007;45:1369-1374. (Pubitemid 351411916)
15. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17; quiz CE11-14.
16. Spensley A, Sripipatana T, Turner AN, et al. Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience. Am J Public Health. 2009;99: 631-637.
17. Hader SL, Smith DK, Moore JS, et al. HIV infection in women in the United States: status at the Millennium. JAMA. 2001;285:1186-1192. (Pubitemid 32198485)
18. Goicoechea M, Smith DM. Universal HIV testing: is it enough? Clin Infect Dis. 2007;45:1375-1376. (Pubitemid 351411917)
19. Grinsztejn B, Veloso VG, Friedman RK, et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2009;23:2107-2114.
20. Qaseem A, Snow V, Shekelle P, et al. Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med. 2009; 150:125-131.